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Previous exposure to the training context disrupts glutamatergic N-methyl-D-aspartate receptor
(NMDAr) antagonist-induced amnesia, indicating that novelty is necessary for such an amnestic effect.
While there are reports that novelty-related release of opioids cause amnesia, no study has addressed
whether the amnestic effect of NMDAr antagonists involve opioid mechanisms. In this study we investi-
gated whether pharmacological manipulation of the opioid system immediately after context pre-
exposure alters the amnestic effect of arcaine, a NMDAr antagonist. Adult male Wistar rats were
habituated (pre-exposed) to a fear conditioning training apparatus or to a different context (open ﬁeld).
Immediately after pre-exposure, animals were injected with saline or naloxone (0.5 mg/kg, i.p.) or anti-
beta-endorphin antibody (1:500, i.c.v.). Forty eight hours after pre-exposure session, all animals were
subjected to fear conditioning acquisition protocol and saline or arcaine (30 mg/kg, i.p.) was administered
immediately after training. Testing was carried out 24 h later, and freezing responses due to re-exposure
to the training apparatus were recorded. Pre-exposure to the training apparatus prevented the impair-
ment of memory induced by post-training arcaine. Administration of naloxone or anti-beta-endorphin
antibody, immediately after pre-exposure to the training apparatus, reinstated the amnesic effect of
post-training arcaine. The results suggest that endogenous opioid mechanisms are involved in the pre-
exposure-induced loss of the amnestic effect of arcaine.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Historical and current evidence suggest that memories are ini-
tially fragile, but become more stable with time (Medina,
Bekinschtein, Cammarota, & Izquierdo, 2008). Such an observation
has led to the concept of memory consolidation, which refers to the
stabilization of a new memory over time by neural processes acti-
vated by recently learned information (Roesler & McGaugh, 2010).
The process of consolidation takes place immediately after the
training experience (Castellano, Cestari, & Ciamei, 2001a) and it de-
pends on glutamatergic transmission (Camera, Mello, Ceretta, &
Rubin, 2007; Castellano et al., 2001a; Izquierdo & medina, 1997;
Rosat, Da-Silva, Zanatta, Medina, & Izquierdo, 1992). However, it
is regulated by other neurotransmitters and neuromodulators,
such as opioids (Castellano, Rojas-Diaz, Martin, Quintero, Alonso,
Navarro, & Gonzalez-Mora, 2001b; Izquierdo, Barcik, & Brioni,ação em Ciências Biológicas,
de Santa Maria, CEP 97105-
bin).
sevier OA license.1989; Izquierdo & Medina, 1997; Medina & Izquierdo, 1995), ace-
tylcholine (Brioni & Arneric, 1993; Rosat et al., 1992; Thiel, Huston,
& Schwarting, 1998; Van der Zee, Douma, Bohus, & Luiten, 1994),
serotonin (Horisawa, Ishibashi, Nishikawa, Enomoto, Toma,
Ishiyama, & Taiji, 2011; Roberts & Hedlund, 2011), norepinephrine
(Ferry, Roozendaal, & McGaugh, 1999), dopamine (Brioni & Arneric,
1993; Darvas, Fadok, & Palmiter, 2011; El-Ghundi, O’Dowd, &
George, 2007), oxytocin (Arletti, Benelli, Poggioli, Luppi, Menozzi,
& Bertolini, 1995; Pagani, Lee, & Young, 2011), BDNF (Slipczuk,
Bekinschtein, Katche, Cammarota, Izquierdo, & Medina, 2009),
GABA (Rosat et al., 1992; Savic, Milinkovic, Rallapalli, Clayton, Jok-
simovic, Van Linn, & Cook, 2009), within others.
The activation of glutamatergic N-methyl-D-aspartate receptors
(NMDAr) in the hippocampus, amygdala and other brain areas
(Cammarota, Bevilaqua, Rossato, Lima, Medina, & Izquierdo,
2008; Izquierdo & Medina, 1997; Roesler, Reolon, Luft, Martins,
Schroder, Vianna, & Quevedo, 2005; Roesler, Schroder, Vianna,
Quevedo, Bromberg, Kapczinski, & Ferreira, 2003) play an
important role in early consolidation of the memory of tasks, such
as inhibitory avoidance (Cammarota et al., 2008; Izquierdo & Med-
ina, 1997; Roesler et al., 2003; Roesler et al., 2005) and fear
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2007; Camera et al., 2007; Gomes, Mello, da Rosa, Bochi, Ferreira,
Barron, & Rubin, 2010; Kalisch, Holt, Petrovic, De Martino, Kloppel,
Buchel, and Dolan, 2009; Liu, Li, Dang, Wang, Rao, Wu, Li, & Wang,
2009; Santini, Muller, & Quirk, 2001). In fact, it has been demon-
strated that immediate post-training, but not delayed
(30–180 min) intra-hippocampal infusion of the NMDA competi-
tive antagonist aminophosphonopentanoic acid – AP5 – (Izquierdo,
da Cunha, Rosat, Jerusalinsky, Ferreira, & Medina, 1992) or of the
glutamate metabotropic receptor antagonist methyl-carboxy-
phenyl glycine (Bianchin, Da Silva, Schmitz, Medina, & Izquierdo,
1994) causes amnesia in the inhibitory avoidance task. Moreover,
systemic administration of the noncompetitive NMDAr antagonist
MK-801, immediately post-training, disrupts memory of the inhib-
itory avoidance task (Ceretta, Camera, Mello, & Rubin, 2008). The
consolidation of long-term memory of one-trial step-down inhibi-
tory avoidance task is blocked by the early post-training infusion of
NMDAr and a-amino-3-hydroxy-5- methyl-4-isoxazole propionate
receptor (AMPAr) antagonists into the CA1 region of the dorsal
hippocampus, and it is associated with a rapid and reversible in-
crease in the total number of [3H]AMPA binding sites (Cammarota,
Bevilaqua, Bonini, Rossatto, Medina, & Izquierdo, 2004).
While NMDAr antagonists disrupt memory in both inhibitory
avoidance and fear conditioning tasks, polyamines, positive modu-
lators of the NMDA receptor in lower concentrations, improve
acquisition and/or early consolidation of inhibitory avoidance
(Rubin, Boemo, Jurach, Rojas, Zanolla, Obregon, Souza, & Mello,
2000; Rubin, Stiegemeier, Volkweis, Oliveira, Fenili, Boemo, Jurach,
& Mello, 2001) and fear conditioning (Gomes et al., 2010; Rubin,
Berlese, Stiegemeier, Volkweis, Oliveira, dos Santos, Fenili, & Mello,
2004) asks. The immediately post-training intra-hippocampal,
intra-amygdala and systemic administration of low doses of
spermidine improves the memory of inhibitory avoidance (Rubin
et al., 2000, 2001) and fear conditioning (Camera et al., 2007; Rubin
et al., 2004). In line with this view, MK-801 reverses the facilitatory
effect of spermidine on the memory of fear (Camera et al., 2007). It
is also remarkable that the facilitatory effects of spermidine are
antagonized by minute amounts of arcaine, an antagonist of the
NMDAr polyamine binding site (Guerra, Mello, Bochi, Pazini, Fachi-
netto, Dutra, Calixto, Ferreira, & Rubin, 2011; Reynolds, 1990; Ru-
bin et al., 2000, 2001, 2004). The systemic and intra-amygdalar
administration of arcaine, at doses higher than those required to
block the facilitatory effects of spermidine, impairs memory of
inhibitory avoidance (Ceretta et al., 2008; Rubin et al., 2001) and
fear conditioning (Camera et al., 2007; Rubin et al., 2004).
One intriguing ﬁnding of the literature is that pre-exposure to
the training apparatus prevents the impairment of memory
induced by NMDAr antagonists. Consistent with this view,
pre-training or pre-exposure to the task apparatus protects from
impairment of inhibitory avoidance memory induced by
post-training intra-hippocampal infusion of the AP5 in rats (Roes-
ler, Vianna, Sant’Anna, Kuyven, Kruel, Quevedo, & Ferreira, 1998;
Roesler et al., 2003, 2005) and systemic injection of MK-801 in
mice (Castellano, Cestari, Ciamei, & Pavone, 1999; Shapiro & O’Con-
nor, 1992).
The effect of pre-exposure on the conditioning stimulus (CS) has
been attributed to a retardation of responding to the CS that is ob-
served when the subject has been exposed to that CS alone.
The following putative mechanisms have been implicated in
pre-exposure induced learning impairment: a decrease in associa-
bility or attention to the CS (Cutler, Mackintosh, & Chance, 1975;
Pearce & Hall, 1980), a response deﬁcit due to a robust CS-context
association (Miller, Barnet, & Grahame, 1992), or arising from
interfering associations to the CS (Bouton, 1993; Miller, Kasprow,
& Schachtman, 1986). Moreover, one should consider that
decreased acquisition scores due to pre-exposition (Hinderliter &Riccio, 1977; Izquierdo & McGaugh, 1987) could mask the amnes-
tic effect the NMDA antagonist (Izquierdo, Schroder, Netto, & Med-
ina, 1999; Roesler et al., 1998; Roesler et al., 2003), due to a
‘‘ground effect’’. In other words, it is difﬁcult to detect an impair-
ment of performance in an already impaired animal.
It is particularly interesting that familiarization with the testing
apparatus also decreases the impairing effects of morphine and of
the opiate k-receptor agonist tiﬂuadom on memory consolidation
of inhibitory avoidance task (Castellano, Pavone, & Puglisi Allegra,
1984; Pavone & Castellano, 1985) and of morphine on contextual
fear conditioning (Rudy, Kuwagama, & Pugh, 1999; Rudy & Pugh,
1996). In fact, Rudy et al., (1999) have suggested that contextual
fear conditioning depends on two independent processes: (a) con-
structing of a unitary representation of the features of the context,
and (b) associating this representation with the aversive shock, and
that opioids could modulate the processes that consolidate a mem-
ory representation of the context.
Seminal studies by Izquierdo and McGaugh (1985), Izquierdo
and McGaugh (1987) on the role of opioids in memory and novelty
have shown that endogenous opioids are released when an animal
is exposed to novelty (Izquierdo & McGaugh, 1985; Netto, Cavalhe-
iro, Carrasco, Volkmer, Dias, & Izquierdo, 1985; Xu, Anwyl, & Ro-
wan, 1998) and have suggested that the opioid system is involved
in the adaptive behavior to novelty. Interestingly, an interaction be-
tween glutamatergic and opioid systems has also been proposed
(Barros, Izquierdo, Medina, & Izquierdo, 2003; Castellano et al.,
1999; Shapiro & O’Connor, 1992), since MK-801 potentiates the
memory impairment induced by opioids (Cestari & Castellano,
1997) and attenuates, or inhibits, the development of tolerance to
morphine-induced analgesia in the rat (Marek, Ben-Eliyahu, Gold,
& Liebeskind, 1991; Trujillo & Akil, 1994). Such an interaction, to
some degree, has been conﬁrmed by the ﬁndings that the NMDA
antagonists MK-801 (Cestari & Castellano, 1997) and arcaine (Mari-
ani, Mello, Rosa, Ceretta, Camera, & Rubin, 2011) abolishmorphine-
induced state dependency. Considering that endogenous opioids
may be neurochemical markers of novelty (Izquierdo & McGaugh,
1985) and that several lines of evidence indicate that the amnestic
of NMDA antagonists depends on novelty, one could propose that
novelty-induced release of endogenous opioids are involved in
the amnestic effect of NMDA antagonists.
Therefore, in this study we investigated whether the pharmaco-
logical manipulation of the opioid system, immediately after
pre-exposure to the conditioning apparatus, alters pre-exposure-
induced impairment of the amnestic effect of arcaine on the
contextual fear conditioning of rats.2. Material and methods
2.1. Animals
Male Wistar rats (220–260 g) were housed ﬁve to cage on a 12-
h light/dark cycle (lights on at 7:00 a.m.) at a temperature of 21 C
with water ad libitum and standard laboratory chow (Guabi, Santa
Maria, Rio Grande do Sul, Brazil). All experimental procedures were
conducted between 9:00 and 16:00 h. All experimental procedures
were in accordance with the Policies on the Use of Animals and Hu-
mans in Neuroscience research, revised and approved by the Soci-
ety for Neuroscience Research in January 1995 and with the
Institutional and National regulations for animal research (process
068/2011).2.2. Drugs
The animals were injected intraperitoneally (i.p.) with saline
(0.9% NaCl), 1,4-diguanidinobutane sulfate (arcaine; Pfaltz & Bauer,
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beta-endorphin antibody (Immunoistar, Wisconsin, USA). All drugs
solutions were prepared daily in saline (0.9% NaCl). Injections were
performed immediately after pre-exposure and/or immediately
after training, in a 1 ml/kg injection volume (i.p.) or 0.3 lL to the
left lateral ventricle (i.c.v.).
2.3. Surgery
Five days before the behavioral procedures, rats used in exper-
iment 3 were implanted, under Equithesin (1% phenobarbital, 2%
magnesium sulfate, 4% chloral hydrate, 42% propyleneglycol, 11%
ethanol; 3 ml/kg, i.p.) anesthesia with one guide cannula (27
gauge) stereotaxically aimed at the left lateral ventricle (A 0 mm;
L1.5 mm; V 2.5 mm), according to Paxinos and Watson (1986).
2.4. Apparatus
Contextual fear conditioning training and testing took place in a
fear conditioning chamber (30  25  25 cm), located in a well-lit
room. The front wall and ceiling of the chamber were made of clear
acrylic plastic, whereas the lateral and rear walls were made of
opaque plastic. The ﬂoor of the chamber consisted of 32 stainless
steel rods (3 mm diameter), spaced 1 cm apart and wired to a
shock generator. The chamber was cleaned with 30% ethylic alco-
hol before and after each rat occupied it.
2.5. Behavioral procedures
2.5.1. Pre-exposure
Pre-exposure took place in the fear conditioning chamber or in
an open ﬁeld (a 56 cm-diameter round open ﬁeld, which ﬂoor was
covered with linoleum), 48 h before fear-conditioning training.
During the pre-exposure session, the animals were allowed to
freely explore the apparatuses for 3 min.
2.5.2. Contextual fear conditioning
Each animal were subjected to a single fear-conditioning train-
ing session as described by Rubin et al. (2004) with some modiﬁca-
tions. In brief, the rat was placed in the conditioning chamber
(conditioned stimulus, CS) and habituated to the apparatus (CS)
for 3 min. Immediately after, three 1 s-0.6 mA footshocks (uncon-
ditioned stimulus, US) were delivered. The shocks were 40 s apart.
After the last CS/US pairing, rats were allowed to stay in the cham-
ber for another 60 s before returning to their home cages.
Twenty four hours after training each rat was placed back in the
conditioning chamber, and a 6 min testing session was performed.
During this time, no shock was given, and every 4 s an instanta-
neous observation of the rat was made to assess whether it was
in freezing, or not. Behavior was judged as freezing if there was
an absence of any visible movement, except for that necessitated
by respiration. Freezing, deﬁned as a stereotypic crouching posi-
tion with complete immobility (except for respiratory move-
ments), was used as a fear-indicating behavior. The data were
converted to the percentage of samples scored as freezing.
2.5.3. Experiment 1 – Effect of pre-exposure on arcaine-induced
amnesia
This experiment was designed to investigate whether arcaine-
induced amnesia depends on the context of pre-exposure. Animals
were pre-exposed to the training apparatus or to the open ﬁeld
during 3 min or remained in the home cage (control). Immediately
after the pre-exposure session the animals were returned to their
home cage and, 48 h later, trained in the fear conditioning appara-
tus as described above. Immediately after training the animals
were injected with saline (0.9% NaCl, 1 ml/kg, i.p.) or arcaine(30 mg/kg, i.p.) and, 24 h later, tested in the fear conditioning
apparatus where their freezing responses were scored, as de-
scribed above (Section 2.5.2.).
2.5.4. Experiment 2 – Effect of naloxone immediately after pre-
exposure on pre-exposure-induced abolishment of the amnestic effect
of arcaine
This experiment was designed to investigate the involvement of
the opioid system in the pre-exposure-induced loss of sensitivity
to arcaine. Animals were pre-exposed to the training apparatus
or to the open ﬁeld during 3 min. Immediately after pre-exposure
session, the animals were injected with saline or naloxone (0.5 mg/
kg i.p.). After injections, rats were returned to their home cages and
48 h later they were trained in the contextual fear conditioning
apparatus as described above. Immediately after training, animals
were injected with saline or arcaine (30 mg/kg, i.p.). 24 h later the
animals were tested in the fear conditioning apparatus and freez-
ing responses were scored as described above (Section 2.5.2.).
2.5.5. Experiment 3 – Effect of beta-endorphin antibody after pre-
exposure on pre-exposure-induced abolishment of the amnestic effect
of arcaine
This experiment was designed to investigate the role of endog-
enous beta-endorphin in the pre-exposure-induced loss of sensi-
tivity to arcaine. Animals were pre-exposed to the training
apparatus or to the open ﬁeld during 3 min. Immediately after
pre-exposure session the animals received unilateral to the left lat-
eral ventricle (0.3 lL, i.c.v.) injection of saline, anti-beta-endorphin
antibody (1:500) or boiled anti-beta-endorphin antibody (1:500)
as an additional control. After injections, rats were returned to
their home cages and, 48 h later, they were trained in the condi-
tioning chamber. Immediately after training the animals were in-
jected with saline or arcaine (30 mg/kg, i.p.). 24 h later the
animals were tested in fear conditioning apparatus and freezing re-
sponses were scored as described above (Section 2.5.2.).
2.6. Statistical analysis
Statistical analyses were carried out by two- or three-way anal-
ysis of variance (ANOVA) with the ‘‘sessions’’ factor treated as
within-subject factor. Two-way ANOVA was followed by post hoc
analyses (Bonferroni’s test). A p < 0.05 was considered signiﬁcant.
In order to meet ANOVA assumptions, data were subjected to arc
sin transformation before statistical analysis.
3. Results
3.1. Experiment 1
Fig. 1 shows the effect of post-training administration of arcaine
on freezing to context in rats subjected to different pre-exposure
conditions: no pre-exposure, pre-exposed to the open ﬁeld; pre-
exposed to the training apparatus. Statistical analysis of fear condi-
tioning scores (two-way ANOVA) revealed a signiﬁcant interaction
between drug by pre-exposure condition [F2,70 = 8.35 p < 0.001].
Post hoc analysis (Bonferroni’s test) revealed that arcaine de-
creased freezing scores (caused amnesia) only in those animals
pre-exposed to the open ﬁeld or not subjected to pre-exposure ses-
sion (naive). Those animals pre-exposed to the training apparatus
did not present the typical amnestic effect of arcaine.
3.2. Experiment 2
Fig. 2 shows the effect of naloxone, given immediately after pre-
exposure to the training apparatus, on the amnestic effect of ar-
Fig. 1. Effect of i.p. post-training administration of saline (0.9% NaCl) or Arcaine
(30 mg/kg) on freezing to context in rats without pre-exposure (No), pre-exposed to
the open ﬁeld (OF) or to the training apparatus (TA). Training to fear conditioning
occurs 48 h after pre-exposure. p < 0.05 compared with saline. Data are the
mean ± SEM (n = 12–13 animals in each group).
Fig. 3. Effect of i.c.v. post pre-exposure administration of saline, boiled anti beta-
endorphin antibody (BAb) or anti beta-endorphin antibody (Ab) and i.p. immedi-
ately post-training saline or arcaine (30 mg/kg) on freezing to context. Training to
fear conditioning occurs 48 h after pre-exposure to the open ﬁeld or to the training
apparatus. p < 0.05 compared with Sal/Sal group. Data are the mean ± SEM (n = 7
animals in each group).
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analysis of fear conditioning scores (three-way ANOVA) revealed a
signiﬁcant drug (Sal or Arc) by antagonist (Sal or Nal) by pre-
exposure condition (open ﬁeld or training apparatus) interaction:
[F1,50 = 17.59; p < 0.001]. These results indicate that naloxone rein-
stated the amnesic effect of post-training arcaine in those animals
pre-exposed to the training apparatus.
3.3. Experiment 3
Fig. 3 shows the effect of i.c.v injection of anti-beta-endorphin
antibody (Ab) or boiled anti-beta-endorphin antibody (BAb) imme-
diately after pre-exposure to the open ﬁeld or to the training appa-
ratus and effect of i.p. injection of arcaine after training on freezing
to context. Statistical analysis of fear conditioning scores (three-
way ANOVA) revealed a signiﬁcant drug (Sal or Arc) by antagonist
(Sal or BAb or Ab) by pre-exposure condition (open ﬁeld or training
apparatus) interaction: [F1,45 = 23.67; p < 0.001]. Anti beta-
endorphin antibody did not prevent the amnestic effect of arcaine
in animals pre-exposed to the open ﬁeld apparatus and allowed
the amnestic effect of arcaine in animals pre-exposed to the train-
ing apparatus.4. Discussion
In the current study we showed that pre-exposure to the train-
ing apparatus prevented the impairment of memory induced by
post-training arcaine, and that the administration of naloxone or
anti-beta-endorphin antibody, immediately after pre-exposure to
the training apparatus, reinstated the amnesic effect of arcaine.Fig. 2. Effect of i.p. post pre-exposure administration of saline, naloxone (Nal,
0.5 mg/kg) and immediately post-training saline or arcaine (Arc, 30 mg/kg) on
freezing to context. Training to fear conditioning occurs 48 h after pre-exposure to
the open ﬁeld or to the training apparatus. p < 0.05 compared with Sal/Sal group.
Data are mean ± SEM (n = 7–8 animals in each group).The ﬁnding that post-training administration of arcaine impairs
contextual fear conditioning (Fig. 1) conﬁrms previous reports that
antagonists of the polyamine binding site at the NMDA receptor
disrupt the memory of inhibitory avoidance (Rubin et al., 2001)
and fear conditioning (Camera et al., 2007; Rubin et al., 2004),
and further support a role for NMDAr in memory formation. In
addition, it also replicates results from different laboratories that
have shown that pre-exposure to the training apparatus signiﬁ-
cantly attenuates or abolishes the amnestic effect of NMDA recep-
tor antagonists in different behavioral paradigms (Caramanos &
Shapiro, 1994; Roesler et al., 1998; Roesler et al., 2003). Based on
these ﬁndings, one might also propose that the amnestic effect of
arcaine is novelty-dependent. The same interpretation could apply
for those studies that have shown that context pre-exposure abol-
ishes the amnestic effect of other NMDA antagonists.
Novelty is a motivationally salient learning signal that attracts
attention, promotes memory encoding and modiﬁes goal-directed
behavior (Boehler, Bunzeck, Krebs, Noesselt, Schoenfeld, Heinze,
Munte, Woldorff, & Hopf, 2011; Knight, 1996; Lisman & Grace,
2005; Mesulam, 1998; Sokolov, 1963). The presence of novelty
usually induces a quick habituation and it is rejected by the rapid
decrease of responding to the new environment or situation (Ca-
hill, Brioni, & Izquierdo, 1986; Izquierdo & Pereira, 1989; Netto
et al., 1985). Likewise other forms of learning (Izquierdo & Medina,
1997), the early phase of memory formation of habituation to a no-
vel environment requires the immediate post-training involve-
ment of NMDA receptors (Izquierdo et al., 1992) and Ca2+/
calmodulin-dependent protein kinase II (Wolfman, Izquierdo,
Schroder, & Izquierdo, 1999).
A functional relationship between novelty and reward-process-
ing by midbrain dopaminergic mechanisms highlights a biological
relevance for novelty as a motivating (Kakade & Dayan, 2002;
Schultz, 1998) and/or reinforcing (Reed, Croft, & Yeomans, 1996)
stimulus in animals and humans (Duzel, Bunzeck, Guitart-Masip,
& Duzel, 2010). The lack of a novelty-induced dopaminergic input
in habituated animals results in decreased motivation, and may ex-
plain why previous exposure to a given apparatus may decrease
associability or attention to the CS (Cutler et al., 1975; Pearce &
Hall, 1980), cause a response deﬁcit due to a robust CS–context
association (Miller et al., 1992), or association interference with
the CS (Bouton, 1993; Miller et al., 1986).
Nevertheless, none of the above considerations explain why ar-
caine and other NMDA antagonists do not cause amnesia in previ-
ously habituated animals, particularly if we consider that, in the
current work, previous habituation to the training apparatus did
not cause learning deﬁcits per se. Therefore, we concluded that pre-
vious habituation may cause not only the removal of novelty-in-
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tic mechanisms.
Various studies have shown that post-training administration of
opioid agonists impairs memory retention in different tasks, such
as inhibitory avoidance (Castellano, Introini-Collison, & McGaugh,
1993; Castellano, Introini-Collison, Pavone, & McGaugh, 1989;
Castellano et al., 1984; Izquierdo, 1979), fear conditioning (Rudy
et al., 1999) and Morris water maze task (Hepner, Homewood, &
Taylor, 2002). Moreover, the post-training administration of nalox-
one facilitates memory and prevents the deleterious effects of
opioid agonists (Castellano et al., 1989). Additional studies have
also shown that opioid agonists induce state dependency (Hill,
Jones, & Bell, 1971; Mariani et al., 2011; Oishi, Nishibori, Itoh,
Saeki, Fukuda, & Araki, 1988; Patti, Kameda, Carvalho, Takatsu-
Coleman, Lopez, Niigaki, Abilio, Frussa-Filho, & Silva, 2006; Shiigi
& Kaneto, 1990; Siegel, 1988; Zarrindast, Askari, Khalilzadeh, &
Nouraei, 2006a; Zarrindast, Bananej, Khalilzadeh, Fazli-Tabaei,
Haeri-Rohani, & Rezayof, 2006b; Zarrindast, Fazli-Tabaei, Ahmadi,
& Yahyavi, 2006c; Zarrindast, Jafari-Sabet, Rezayat, Djahanguiri, &
Rezayof, 2006d; Zarrindast, Noorbakhshnia, Motamedi, Haeri-Roh-
ani, & Rezayof, 2006e) and enhance retrieval when given before
memory tests (Cahill & McGaugh, 1998).
Interestingly, an interaction between the glutamatergic and
opioid systems in memory modulation has been proposed. It has
been shown that the NMDAr antagonist MK-801 potentiates mor-
phine-induced amnesia (Cestari & Castellano, 1997) and that mor-
phine and arcaine induce cross state-dependency in rats (Mariani
et al., 2011). Moreover, naltrexone reverses the memory disruption
induced by MK-801 in the inhibitory avoidance task (Castellano
et al., 1999), suggesting the involvement of opioid mechanisms
in the memory impairment induced by the NMDA antagonist. Nev-
ertheless, it has also been reported that pre-training MK-801 inhib-
its state dependency caused by opioids (Zarrindast et al., 2006d).
Fig. 2 shows that the administration of naloxone, immediately
after pre-exposure, reinstated the amnestic effect of arcaine on
contextual fear conditioning. These results suggest that opioid
receptor-mediated responses elicited during the pre-exposure to
the training apparatus are involved in the loss of the amnestic ef-
fect of arcaine. Since novelty-induced b-endorphin release has
been implicated as a marker for novelty, it is possible blocking b-
endorphin binding sites with naloxone also impaired novelty
recognition.
In order to determine if endogenous beta-endorphin was in-
volved in pre-exposure-induced insensitivity to the effects of ar-
caine, we tested whether anti beta-endorphin antibody
prevented the effect of pre-exposure. Fig. 3 shows that anti-beta-
endorphin antibody administration, immediately after pre-expo-
sure, reinstated the amnestic effect of arcaine in animals
previously exposed to the training apparatus and did not prevent
the arcaine amnestic effect on memory in animals previously ex-
posed to the open ﬁeld. These results suggest that the amnesic ef-
fect of arcaine depends, at least in part, on endogenous opioid
mechanisms.
In summary, the present study describes by using two different
pharmacological approaches, that opioid mechanisms are involved
in the pre-exposure-induced insensistivity to the amnestic effect of
the putative NMDA antagonist arcaine.
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